FDA's Plan B OTC Switch Decision Deadline Is Sept. 1, HHS' Leavitt Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Sens. Clinton and Murray lift their hold on FDA Acting Commissioner Crawford's nomination after a letter from HHS secretary says FDA action on Barr's Rx-to-OTC switch application is imminent.
You may also be interested in...
FDA Appoints Assistant Commissioner For Science Ahead Of Plan B Decision
Former Center for Veterinary Medicine Deputy Director Linda Tollefson will oversee FDA's Offices of Women's Health and Orphan Products Development.
FDA Appoints Assistant Commissioner For Science Ahead Of Plan B Decision
Former Center for Veterinary Medicine Deputy Director Linda Tollefson will oversee FDA's Offices of Women's Health and Orphan Products Development.
Crawford Nomination To Be FDA Commissioner Clears Senate 78-16
Three Republicans, 13 Democrats vote against the acting commissioner. Finance Committee chair Grassley says that Crawford “has not stepped up to the plate” to address systemic problems at FDA.